Generex Biotechnology Corporatio (GNBT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | GNBT | ZTS | TAK | NBIX | UTHR |
| Company | Generex Biotechnology Corporatio | Zoetis Inc Cl A | Takeda Pharmaceutical Ltd ADR | Neurocrine Bioscienc | United Therapeutic |
| Price Information | |||||
| Exchange | OTC US | NYSE | NYSE | NASDAQ | NASDAQ |
| Open | 0.0006 | 167.35 | 13.41 | 140.55 | 263.63 |
| High | 0.0006 | 167.62 | 13.41 | 143.57 | 264.85 |
| Low | 0.0006 | 164.88 | 13.31 | 140.55 | 256.08 |
| Last | 0.0006 | 165.95 | 13.36 | 141.71 | 260.51 |
| Change | unch | -1.12 | -0.01 | +1.00 | -1.89 |
| % Change | unch | -0.67% | -0.07% | +0.71% | -0.72% |
| Volume | 1,000 | 3,081,300 | 1,575,600 | 495,100 | 587,200 |
| 20-Day Average Volume | 20,645 | 4,613,185 | 1,600,810 | 797,330 | 563,660 |
| Previous Close | 0.0006 | 167.07 | 13.37 | 140.71 | 262.40 |
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | Medical - Drugs | Medical - Drugs |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 0.0007 | 156.64 | 13.28 | 136.91 | 240.29 |
| 20-Day Raw Stochastic | 0.00% | 78.65% | 51.82% | 76.74% | 87.41% |
| 20-Day Relative Strength | 45.72% | 51.77% | 43.83% | 56.03% | 66.11% |
| Weighted Alpha | -88.85 | -11.22 | -18.35 | +46.61 | +25.04 |
| Today's Opinion | 100% Sell | 56% Sell | 88% Sell | 88% Buy | 88% Buy |
| Previous Opinion | 100% Sell | 56% Sell | 88% Sell | 88% Buy | 88% Buy |
| Last Month's Opinion | 80% Sell | 56% Sell | 88% Sell | 88% Buy | 16% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | unch since 10/20/22 | +3.91% since 04/29/24 | +1.44% since 04/29/24 | +2.03% since 04/29/24 | +9.34% since 04/29/24 |
| Low | 0.0006 on 10/27/22 | 158.04 on 05/01/24 | 13.08 on 05/01/24 | 136.01 on 05/01/24 | 233.31 on 04/30/24 |
| High | 0.0007 on 10/26/22 | 171.69 on 05/03/24 | 13.41 on 05/06/24 | 145.22 on 05/01/24 | 264.85 on 05/06/24 |
| 1-Month | |||||
| %Chg | -14.29% since 09/27/22 | +0.05% since 04/05/24 | -1.91% since 04/05/24 | +2.01% since 04/05/24 | +11.54% since 04/05/24 |
| Low | 0.0006 on 10/27/22 | 144.80 on 04/22/24 | 13.01 on 04/26/24 | 130.13 on 04/19/24 | 230.39 on 04/16/24 |
| High | 0.0008 on 10/05/22 | 171.69 on 05/03/24 | 13.77 on 04/08/24 | 145.22 on 05/01/24 | 264.85 on 05/06/24 |
| 3-Month | |||||
| %Chg | -60.00% since 07/27/22 | -15.39% since 02/06/24 | -5.65% since 02/06/24 | -0.87% since 02/06/24 | +21.20% since 02/06/24 |
| Low | 0.0006 on 10/27/22 | 144.80 on 04/22/24 | 13.01 on 04/26/24 | 128.00 on 02/07/24 | 208.62 on 02/08/24 |
| High | 0.0497 on 08/25/22 | 200.53 on 02/29/24 | 14.88 on 02/27/24 | 148.37 on 03/21/24 | 264.85 on 05/06/24 |
| 6-Month | |||||
| %Chg | -70.00% since 04/27/22 | +1.70% since 11/06/23 | -2.55% since 11/06/23 | +24.30% since 11/06/23 | +14.17% since 11/06/23 |
| Low | 0.0001 on 05/26/22 | 144.80 on 04/22/24 | 13.01 on 04/26/24 | 103.63 on 11/10/23 | 208.62 on 02/08/24 |
| High | 0.0497 on 08/25/22 | 201.92 on 12/14/23 | 15.07 on 01/12/24 | 148.37 on 03/21/24 | 264.85 on 05/06/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 73 | 76,410,976 | 42,313,872 | 14,160,632 | 11,641,639 |
| Shares Outstanding, K | 122,058 | 457,359 | 3,164,837 | 100,637 | 44,366 |
| Annual Sales | 2,660,000 | 8,544,000,000 | 29,803,340,000 | 1,887,100,000 | 2,327,500,000 |
| Annual Net Income | -33,340,000 | 2,344,000,000 | 2,345,930,000 | 249,700,000 | 984,800,000 |
| Last Quarter Sales | N/A | 2,213,000,000 | 7,556,070,000 | 515,200,000 | 614,700,000 |
| Last Quarter Net Income | N/A | 525,000,000 | 718,900,000 | 147,700,000 | 217,100,000 |
| 60-Month Beta | -0.07 | 0.86 | 0.56 | 0.28 | 0.54 |
| Per-Share Information | |||||
| Most Recent Earnings | N/A | 1.38 on 05/02/24 | 0.51 on 02/01/24 | 0.42 on 05/01/24 | 6.17 on 05/01/24 |
| Latest Earnings Date | 08/01/22 | 05/02/24 | 05/09/24 | 05/01/24 | 05/01/24 |
| Most Recent Dividend | N/A | 0.432 on 04/18/24 | 0.261 on 09/28/23 | N/A | N/A |
| Next Ex-Dividends Date | N/A | 04/18/24 | 09/28/23 | N/A | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 31.03 | 6.81 | 38.52 | 12.20 |